The surface modification of NPs with biological ligands, such as folate, arginine-glycine-aspartate (RGD) peptides, aptamers, transferrin, antibodies or small antibody fragments, facilitates NP targeting, imaging and internalization into specific cells, e.g., cancer cells, and tumor tissues. Here, TF is linked to cancer.